Amira Barkal

7.0k total citations · 2 hit papers
11 papers, 2.0k citations indexed

About

Amira Barkal is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Amira Barkal has authored 11 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 1 paper in Cell Biology. Recurrent topics in Amira Barkal's work include Phagocytosis and Immune Regulation (5 papers), Genomics and Chromatin Dynamics (5 papers) and CRISPR and Genetic Engineering (2 papers). Amira Barkal is often cited by papers focused on Phagocytosis and Immune Regulation (5 papers), Genomics and Chromatin Dynamics (5 papers) and CRISPR and Genetic Engineering (2 papers). Amira Barkal collaborates with scholars based in United States, India and Singapore. Amira Barkal's co-authors include Irving L. Weissman, Layla J. Barkal, Maxim Markovic, Oliver Dorigo, Venkatesh Krishnan, Balyn W. Zaro, Rachel Brewer, Mark Kowarsky, Jason Hatakeyama and David K. Gifford and has published in prestigious journals such as Nature, Nature Biotechnology and Nature Immunology.

In The Last Decade

Amira Barkal

11 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

2019 956 citations Amira Barkal, Rachel Brewer et al. Nature profile →
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

2017 428 citations Amira Barkal, Kipp Weiskopf et al. Nature Immunology profile →

Peers

Countries citing papers authored by Amira Barkal

Since Specialization

Citations

This map shows the geographic impact of Amira Barkal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amira Barkal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amira Barkal more than expected).

Fields of papers citing papers by Amira Barkal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amira Barkal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amira Barkal. The network helps show where Amira Barkal may publish in the future.

Co-authorship network of co-authors of Amira Barkal

This figure shows the co-authorship network connecting the top 25 collaborators of Amira Barkal. A scholar is included among the top collaborators of Amira Barkal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amira Barkal. Amira Barkal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect 2022 ·Nature Cancer ·Yoko Nishiga, Alexandros P. Drainas, (unknown), Debadrita Bhattacharya, Amira Barkal, (unknown), Rebecca Mancusi, Jason Ross, Nobuyuki Takahashi, Anish Thomas, Maximilian Diehn, Irving L. Weissman, Edward E. Graves, Julien Sage	106
2	Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis 2021 ·Nature ·Roarke A. Kamber, Yoko Nishiga, (unknown), Allison Banuelos, Amira Barkal, Felipe Vences‐Catalán, Mingxin Gu, Daniel Fernández, José A. Seoane, David Yao, Katherine Liu, Sijie Lin, Kaitlyn Spees, Christina Curtis, Livnat Jerby‐Arnon, Irving L. Weissman, Julien Sage, Michael C. Bassik	118
3	CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy breakdown → 2019 ·Nature ·Amira Barkal, Rachel Brewer, Maxim Markovic, Mark Kowarsky, (unknown), Balyn W. Zaro, Venkatesh Krishnan, Jason Hatakeyama, Oliver Dorigo, Layla J. Barkal, Irving L. Weissman	956
4	DNase-capture reveals differential transcription factor binding modalities 2017 ·PLoS ONE ·Daniel Kang, Richard I. Sherwood, Amira Barkal, Tatsunori Hashimoto, Logan Engstrom, David K. Gifford	1
5	Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy breakdown → 2017 ·Nature Immunology ·Amira Barkal, Kipp Weiskopf, Kevin S. Kao, Sydney Gordon, Benyamin Rosental, Ying Ying Yiu, Benson M. George, Maxim Markovic, Nan Ring, Jonathan M. Tsai, Kelly M. McKenna, Po Y. Ho, Robin Z. Cheng, James Y. Chen, Layla J. Barkal, Aaron M. Ring, Irving L. Weissman, Roy L. Maute	428
6	Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20 2016 ·Cancer Immunology Research ·Kipp Weiskopf, Katie L. Anderson, Daisuke Ito, Peter J. Schnorr, Hirotaka Tomiyasu, Aaron M. Ring, (unknown), Jem Efe, Sarah Rue, David E. Lowery, Amira Barkal, Susan Prohaska, Kelly M. McKenna, Ingrid Cornax, Timothy D. O’Brien, Maeve O’Sullivan, Irving L. Weissman, Jaime F. Modiano	43
7	An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm development 2016 ·Scientific Data ·Pang Wei Koh, Rahul Sinha, Amira Barkal, (unknown), Angela C. Chen, Irving L. Weissman, Lay Teng Ang, Anshul Kundaje, Kyle M. Loh	35
8	A synergistic DNA logic predicts genome-wide chromatin accessibility 2016 ·Genome Research ·Tatsunori Hashimoto, Richard I. Sherwood, Daniel Kang, Nisha Rajagopal, Amira Barkal, Haoyang Zeng, (unknown), Sharanya Srinivasan, Tommi Jaakkola, David K. Gifford	12
9	Cas9 Functionally Opens Chromatin 2016 ·PLoS ONE ·Amira Barkal, Sharanya Srinivasan, Tatsunori Hashimoto, David K. Gifford, Richard I. Sherwood	26
10	Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape 2014 ·PMC ·Richard I. Sherwood, Tatsunori Hashimoto, Colm P. O’Donnell, Sophia Lewis, Amira Barkal, (unknown), (unknown), Tommi Jaakkola, David K. Gifford	3
11	Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape 2014 ·Nature Biotechnology ·Richard I. Sherwood, Tatsunori Hashimoto, Colm P. O’Donnell, Sophia Lewis, Amira Barkal, (unknown), (unknown), Tommi Jaakkola, David K. Gifford	315

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact